Gene · 4437
Papers3,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 3,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance. | Pharmacol Res | 2021 | 34302977 | PubTator, text mining | PubMed |
| Tetranucleotide and Low Microsatellite Instability Are Inversely Associated with the CpG Island Methylator Phenotype in Colorectal Cancer. | Cancers (Basel) | 2021 | 34298744 | PubTator, text mining | PubMed |
| Exploiting DNA Damage Repair in Precision Cancer Therapy: BRCA1 as a Prime Therapeutic Target. | Cancers (Basel) | 2021 | 34298653 | PubTator, text mining | PubMed |
| Unbiased Proteomic and Phosphoproteomic Analysis Identifies Response Signatures and Novel Susceptibilities After Combined MEK and mTOR Inhibition in BRAFV600E Mutant Glioma. | Mol Cell Proteomics | 2021 | 34298159 | PubTator, text mining | PubMed |
| DNA-PKc inhibition overcomes taxane resistance by promoting taxane-induced DNA damage in prostate cancer cells. | Prostate | 2021 | 34297853 | PubTator, text mining | PubMed |
| Fission yeast Rad8/HLTF facilitates Rad52-dependent chromosomal rearrangements through PCNA lysine 107 ubiquitination. | PLoS Genet | 2021 | 34292936 | PubTator, text mining | PubMed |
| Prevalence of cancer susceptibility variants in patients with multiple Lynch syndrome related cancers. | Sci Rep | 2021 | 34285288 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Mediators of Cancer Disease and as Nanosystems in Theranostic Applications. | Cancers (Basel) | 2021 | 34283059 | PubTator, text mining | PubMed |
| Incidental findings from cancer next generation sequencing panels. | NPJ Genom Med | 2021 | 34282142 | PubTator, text mining | PubMed |
| OncoThreads: visualization of large-scale longitudinal cancer molecular data. | Bioinformatics | 2021 | 34252935 | PubTator, text mining | PubMed |
| Prevalence and Characterization of Biallelic and Monoallelic NTHL1 and MSH3 Variant Carriers From a Pan-Cancer Patient Population. | JCO Precis Oncol | 2021 | 34250384 | PubTator, text mining | PubMed |
| Tumor Immune Microenvironment and Genetic Alterations in Mesothelioma. | Front Oncol | 2021 | 34249695 | PubTator, text mining | PubMed |
| Genomic analyses of high-grade neuroendocrine gynecological malignancies reveal a unique mutational landscape and therapeutic vulnerabilities. | Mol Oncol | 2021 | 34245124 | PubTator, text mining | PubMed |
| The shaping of a molecular linguist: How a career studying DNA energetics revealed the language of molecular communication. | J Biol Chem | 2021 | 34237886 | PubTator, text mining | PubMed |
| Fallopian tube cancer- challenging to diagnose but not as infrequent as originally thought. | J Community Hosp Intern Med Perspect | 2021 | 34234914 | PubTator, text mining | PubMed |
| Isolation and Characterization of Chemo-Resistant Stem Cells from a Mouse Model of Hereditary Non-Polyposis Colon Cancer. | Stem Cells Cloning | 2021 | 34234468 | PubTator, text mining | PubMed |
| Untangling the genetic link between type 1 and type 2 diabetes using functional genomics. | Sci Rep | 2021 | 34230558 | PubTator, text mining | PubMed |
| FANCD2-Associated Nuclease 1 Partially Compensates for the Lack of Exonuclease 1 in Mismatch Repair. | Mol Cell Biol | 2021 | 34228493 | PubTator, text mining | PubMed |
| DNA Repair Gene Polymorphisms and Chromosomal Aberrations in Exposed Populations. | Front Genet | 2021 | 34220964 | PubTator, text mining | PubMed |
| DNA double-strand break repair gene mutation and the risk of papillary thyroid microcarcinoma: a case-control study. | Cancer Cell Int | 2021 | 34215272 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4437/papers?page=47